Supernus Pharmaceuticals | SUPN - 普通股股本

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.43B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	普通股股本	更改		日
Abbott	USD 1.74B		23.39B	2025-09
ANI Pharmaceuticals	USD 22.49M		760K	2025-12
Aurora Cannabis	CAD 56.71M		134.13K	2025-12
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Canopy Growth	CAD 368.28M		35.9M	2025-12
Cara Therapeutics	USD 9.38M		9.38M	2025-09
Corcept Therapeutics	USD 107.33M		1.36M	2026-03
Eisai	JPY 282.11M		0	2026-03
Eli Lilly	USD 943.5M		3.33M	2026-03
Novo Nordisk	DKK 4.44B		0	2025-12
Pacira	USD 39.31M		1.81M	2026-03
Perrigo	USD 138.1M		500K	2026-03
Pfizer	USD 5.7B		13M	2026-03
Supernus Pharmaceuticals	USD 58.04M		582K	2026-03
United Therapeutics	USD 42.16M		1.49M	2026-03
Xeris Pharmaceuticals	USD 166.22M		687.16K	2025-12